Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | SNCA | P37840 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3535118 | 0.81 | PTGS2 (0.40) | HSP90AA1CYP1A2CYP3A4CYP2C9TSHR | |
| SCHEMBL3529911 | 0.79 | HSP90AA1 (0.38) | HSP90AA1CYP1A2CYP3A4CYP2C9TSHR | |
| SCHEMBL3532986 | 0.77 | CYP1A2 (0.41) | HSP90AA1CYP1A2CYP3A4CYP2C9TSHR | |
| SCHEMBL10039090 | 0.75 | HSP90AA1 (0.38) | HSP90AA1CYP1A2CYP3A4CYP2C9TSHR | |
| SCHEMBL3532736 | 0.74 | HSP90AA1 (0.34) | HSP90AA1CYP1A2CYP3A4CYP2C9TSHR | |
| SCHEMBL3538222 | 0.72 | HSP90AA1 (0.38) | HSP90AA1CYP1A2CYP3A4CYP2C9TSHR | |
| SCHEMBL13368157 | 0.72 | ALOX5 (0.33) | PTGS1PTGS2 | |
| SCHEMBL3532469 | 0.71 | HSP90AA1 (0.34) | HSP90AA1CYP1A2CYP3A4CYP2C9TSHR | |
| SCHEMBL5834099 | 0.71 | NPC1 (0.38) | HSP90AA1CYP1A2CYP3A4CYP2C9TSHR | |
| SCHEMBL11079994 | 0.71 | NPC1 (0.38) | HSP90AA1CYP1A2CYP3A4CYP2C9TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7714099-B2 | Luminescent compositions and their uses | HITACHI CHEMICAL CO., LTD. (JP) | 2010-05-11 | — | — | US | disclosed |
| US-7714099-B2 | Luminescent compositions and their uses | HITACHI CHEMICAL CO., LTD. (JP) | 2010-05-11 | — | — | US | disclosed |
| US-7714099-B2 | Luminescent compositions and their uses | HITACHI CHEMICAL CO., LTD. (JP) | 2010-05-11 | — | — | US | disclosed |
| US-20060083945-A1 | New luminescent compositions and their uses | HITACHI CHEMICAL CO. LTD. (JP) | 2006-04-20 | — | — | US | disclosed |
| WO-2006041221-A1 | NEW LUMINESCENT COMPOSITIONS AND THEIR USES | HITACHI CHEMICAL CO., LTD. (JP) | 2006-04-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060083945-A1 | New luminescent compositions and their uses | OCIAD1, NLRP3, OCIAD2 | HSP90AA1 4435/4885SNCA 2388/4885CYP1A2 4297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.